GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

DARE · Mar 31, 2026

Dare Bioscience, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0001401914-26-000026General Corporate

Capex intensity9thOwn-history percentile · N=11

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.00% · OPTIONAL · VALID

Operating cash generation40thOwn-history percentile · N=10

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-3621.16% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.revenue

499.58% · CORE · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.gross_margin

-58.95% · CORE · NOT_ENOUGH_HISTORY

Operating margin55thOwn-history percentile · N=11

Evidence method

Level · gp.fundamentals.operating_margin

-1967.07% · CORE · VALID

R&D intensity10thOwn-history percentile · N=10

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

433.22% · OPTIONAL · VALID

SBC intensity45thOwn-history percentile · N=11

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

298.49% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History9 statesHistory building

Dec 31, 20230/6 normalizedLevel 3 Sep 30, 20240/6 normalizedLevel 3 Dec 31, 20240/6 normalizedLevel 3 Mar 31, 20250/6 normalizedLevel 3 Jun 30, 20253/4 normalizedLevel 3 Sep 30, 20255/6 normalizedLevel 3 Dec 31, 20255/7 normalizedLevel 3 Mar 31, 20265/7 normalizedLevel 3 Jun 30, 20265/6 normalizedLevel 3

Period transition

What moved in the state?

Capex Intensity Decreased

Previous: 37.40%
Current: 0.00%
Delta: -37.40%

Cash Generation Decreased

Previous: -959.61%
Current: -3621.16%
Delta: -2661.55%

Growth Decreased

Previous: 10429.36%
Current: 499.58%
Delta: -9929.79%

Margin Decreased

Previous: 71.29%
Current: -58.95%
Delta: -130.24%

Profitability Decreased

Previous: -1315.51%
Current: -1967.07%
Delta: -651.56%

R And D Intensity Decreased

Previous: 536.15%
Current: 433.22%
Delta: -102.93%

Sbc Intensity Increased

Previous: 145.27%
Current: 298.49%
Delta: 153.22%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Transitioned To · DARE Fundamental State →Transitioned To · DARE Fundamental State →Transitioned To · DARE CAPEX_INTENSITY_DECREASED →Transitioned To · DARE CASH_GENERATION_DECREASED →Transitioned To · DARE GROWTH_DECREASED →Transitioned To · DARE MARGIN_DECREASED →Transitioned To · DARE PROFITABILITY_DECREASED →Transitioned To · DARE R_AND_D_INTENSITY_DECREASED →Transitioned To · DARE SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.